Live
FierceBiotechChutes & Ladders—Bayer radiology head takes top U.S. pharma spotEndpoints NewsOpenLoop Health has acquired nutrition startup Season HealthFierceBiotechPremier Radiology acquires teleradiology specialist GLOBISFierceBiotech‘Portfolio assessment’ prompts Ferring to terminate 2 fertility trialsFierceBiotechUK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investmentsEndpoints NewsTrump signs order to put 100% pharma tariffs on drugs, countries without trade dealsScienceHow fast is the universe expanding? Cosmic ‘illusions’ may hold answerEndpoints NewsAspect Biosystems gets $79M from Canadian government for diabetes cell therapyLonza NewsFormulating Plant-Based and Organic Supplements: A Conversation with Lonza CHI - Nutritional OutlookEndpoints NewsDOJ weighs in favor of pharma on 340B disputeEndpoints NewsThe peptide fad lures health techIlluminaUPC refuses early knockout in Illumina–Element dispute - Life Sciences Intellectual Property Review
FierceBiotech Apr 2, 2026

UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments

UK signs off on US pharma deal, ensuring tariff reprieve as Britain aims to reattract investments

Original
Body unavailable. Use the original source.

Directory

59 All